Patents by Inventor Adam Robles

Adam Robles has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • SYSTEM FOR IDENTIFYING, MONITORING, INFLUENCING AND REWARDING HEALTHCARE BEHAVIOR
    Publication number: 20130226608
    Abstract: Systems and methods for identifying, monitoring, influencing and rewarding positive healthcare behavior are provided. The method and system includes a device receiving patient specific data which include patient care indicators associated with the patient. The device compares the patient specific data against a database that relates each patient care indicator with at least one patient care module. The device generates customized patient care plan that includes patient care modules. The patient specific data also includes one or more compliance indicators, indicating the patient's interactions with the patient care modules. The device assesses patient behavior based on the compliance indicator.
    Type: Application
    Filed: February 28, 2013
    Publication date: August 29, 2013
    Inventors: Christopher Di Lascia, Francis Di Lascia, Raman Kapur, Wilfred Shearer, Edward Sadowski, Jason Riddle, Adam Robles
  • Quinoline and pyridine anchors for HMG-CoA reductase inhibitors
    Patent number: 5691322
    Abstract: Compounds which are useful as inhibitors of cholesterol biosynthesis and thus as hypocholesterolemic agents are provided which have a quinoline or a pyridine anchor attached by means of a linker to a binding domain sidechain, which compounds inhibit the enzyme 3-hydroxy-3-methyl-glutaryl-coenzyme A reductase.
    Type: Grant
    Filed: October 31, 1995
    Date of Patent: November 25, 1997
    Assignee: E.R. Squibb & Sons, Inc.
    Inventor: Jeffrey Adam Robl
  • Quinoline and pyridine anchors for HMG-CoA reductase inhibitors
    Patent number: 5686433
    Abstract: Compounds which are useful as inhibitors of cholesterol biosynthesis and thus as hypocholesterolemic agents are provided which have a quinoline or a pyridine anchor attached by means of a linker to a binding domain sidechain, which compounds inhibit the enzyme 3-hydroxy-3-methyl-glutaryl-coenzyme A reductase.
    Type: Grant
    Filed: November 2, 1995
    Date of Patent: November 11, 1997
    Assignee: E.R. Squibb & Sons, Inc.
    Inventor: Jeffrey Adam Robl